Search research articles
Contact Us
Filters
Showing results (141-150 of 712) with videos related to
Page
of 72
Sort By:
Learning & Memory (Cold Spring Harbor, N.Y.)
|
May 17, 2017
Response-specific sex difference in the retention of fear extinction
Meagan E Voulo, Ryan G Parsons
Archives of Disease in Childhood
|
October 30, 2010
Studies in the Anæmias of Infancy and Early Childhood: Part V. The hæmolytic (erythronoclastic) anæmias of later infancy and childhood: with special reference to the acute hæmolytic anæmia of Lederer and the anæmia of von Jaksch
L G Parsons, J C Hawksley
Archives of Disease in Childhood
|
October 30, 2010
Generalized Angiomatosis Presenting the Clinical Characteristics of Storage Reticulosis: With Some Observations on the Reticulo-Endothelioses
L G Parsons, J H Ebbs
Methods in Molecular Biology (Clifton, N.J.)
|
July 16, 2014
Patch clamp combined with voltage/concentration clamp to determine the kinetics and voltage dependency of N-methyl-D-aspartate (NMDA) receptor open channel blockers
Chris G Parsons, Kate E Gilling
British Journal of Pharmacology
|
October 1, 1989
Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus
C G Parsons, P M Headley
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Sex difference in the facilitation of fear learning by prior fear conditioning
Kehinde E Cole, Ryan G Parsons
Biochemical Pharmacology
|
February 15, 1990
Effects of antimetabolites on adenovirus replication in sensitive and resistant human melanoma cell lines
P Musk, A Stowers, P G Parsons
Neuropharmacology
|
May 1, 1994
Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466)
C G Parsons, R Gruner, J Rozental
Drug News & Perspectives
|
December 24, 2004
Glutamate in CNS disorders as a target for drug development: an update
C G Parsons, W Danysz, G Quack
Handbook of Experimental Pharmacology
|
April 6, 2006
Excitatory amino acid neurotransmission
C G Parsons, W Danysz, W Zieglgänsberger
Page
of 72
Search research articles
Search
Showing results (141-150 of 712) with videos related to
Sort By:
Page
of 72
Learning & Memory (Cold Spring Harbor, N.Y.)
|
May 17, 2017
Response-specific sex difference in the retention of fear extinction
Meagan E Voulo, Ryan G Parsons
Archives of Disease in Childhood
|
October 30, 2010
Studies in the Anæmias of Infancy and Early Childhood: Part V. The hæmolytic (erythronoclastic) anæmias of later infancy and childhood: with special reference to the acute hæmolytic anæmia of Lederer and the anæmia of von Jaksch
L G Parsons, J C Hawksley
Archives of Disease in Childhood
|
October 30, 2010
Generalized Angiomatosis Presenting the Clinical Characteristics of Storage Reticulosis: With Some Observations on the Reticulo-Endothelioses
L G Parsons, J H Ebbs
Methods in Molecular Biology (Clifton, N.J.)
|
July 16, 2014
Patch clamp combined with voltage/concentration clamp to determine the kinetics and voltage dependency of N-methyl-D-aspartate (NMDA) receptor open channel blockers
Chris G Parsons, Kate E Gilling
British Journal of Pharmacology
|
October 1, 1989
Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus
C G Parsons, P M Headley
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Sex difference in the facilitation of fear learning by prior fear conditioning
Kehinde E Cole, Ryan G Parsons
Biochemical Pharmacology
|
February 15, 1990
Effects of antimetabolites on adenovirus replication in sensitive and resistant human melanoma cell lines
P Musk, A Stowers, P G Parsons
Neuropharmacology
|
May 1, 1994
Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466)
C G Parsons, R Gruner, J Rozental
Drug News & Perspectives
|
December 24, 2004
Glutamate in CNS disorders as a target for drug development: an update
C G Parsons, W Danysz, G Quack
Handbook of Experimental Pharmacology
|
April 6, 2006
Excitatory amino acid neurotransmission
C G Parsons, W Danysz, W Zieglgänsberger
Page
of 72